PCSK 9 Inhibitor Added to High-Intensity Statin Therapy to Prevent Cardiovascular Events in Patients With ACS After PCI
Clinical trial NCT05457582 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05457582
- Sponsor
- Nanjing First Hospital, Nanjing Medical University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-30
- Primary completion
- 2026-12-30
- Enrollment
- 1212
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.